Schizophrenia Cognition Scale Development

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
SchizophreniaCognition Disorders
Trial Locations (4)

10312

Richmond Behavior Associates, Staten Island

21285

Sheppard Pratt Health System, Baltimore

02114

Massachusetts General Hospital, Boston

08854

Rutgers University Robert Wood Johnson Medical School, Piscataway

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Carelon Research

OTHER

NCT02118571 - Schizophrenia Cognition Scale Development | Biotech Hunter | Biotech Hunter